Companies: 10,795·Total market cap: $144.5T
HeartSciences Inc.

HeartSciences Inc.

HSCSNASDAQHealthcare● Active
$1.84
$-0.10(-5.15%)
Market Cap$3987740
P/E Ratio
52W High$6.47
52W Low$1.63

HeartSciences Inc. (HSCS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

hscs · pe ratio · data through Apr 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for HeartSciences Inc. (HSCS) measures how much investors pay for each dollar of the company's trailing earnings. HSCS's current PE ratio of N/A is calculated by dividing its stock price of $1.84 by its TTM earnings per share of -$2.68.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-04-30

Forward P/E
N/A
FY2027 est. EPS $-3.02
Based on 1 analyst
EPS (TTM)
-$2.68
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HeartSciences Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
HeartSciences Inc.
HeartSciences Inc.You
HSCS
$4MN/A-$2.68
Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc. Common Stock
AMIX
$2MN/A-$0.23
Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc.
BCLI
$9MN/A-$1.11
Biomerica, Inc.
Biomerica, Inc.
BMRA
$6MN/A-$2.16
GBS Inc.
GBS Inc.
GBS
$0MN/A-$2.00
Impact BioMedical Inc.
Impact BioMedical Inc.
IBO
$7MN/A-$0.38
Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc.
MTNB
$5MN/A-$1.89

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-04-30Latest
FY2025
$-9.34
2024-04-30
FY2024
$-18.74
2023-04-30
FY2023
$-79.92
2022-04-30
FY2022
$-145.48
2021-04-30
FY2021
$-74.00
2020-04-30
FY2020
$-115.01

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for HeartSciences Inc. (HSCS) measures how much investors pay for each dollar of the company's trailing earnings. HSCS's current PE ratio of N/A is calculated by dividing its stock price of $1.84 by its TTM earnings per share of -$2.68.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.84 ÷ -$2.68 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

HSCS pe ratio · 6 questions

HSCS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.84 and TTM EPS of -$2.68. Data sourced from Financial Modeling Prep via HSCS's SEC 10-K and 10-Q filings.

HSCS PE ratioWhat is HSCS PE ratioCurrent PE ratio of HSCSHSCS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HeartSciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08